Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Draximage Mdp-25 25 mg Powder For Solution is a Health Canada–registered radiopharmaceutical drug (DIN 02329239) held by Jubilant Draximage Inc. Dba Jubilant Radiopharma, containing Medronic Acid. Health Canada lists its status as Marketed (status date 23 Aug 2018). Nexara Health has matched 3 registrations of Medronic Acid across 2 other regulated markets.

Health Canada registration

DIN02329239
Brand nameDraximage Mdp-25
Active ingredientMedronic Acid
Strength25 mg
Dosage formPowder For Solution
RouteIntravenous
CompanyJubilant Draximage Inc. Dba Jubilant Radiopharma
StatusMarketed — 23 Aug 2018
ClassRadiopharmaceutical
ATCV09BA02 TECHNETIUM (99m Tc) MEDRONIC ACID
AHFS36:68.00
Regulator recordHealth Canada DPD entry · Product monograph

Medronic Acid registered in other markets

3 registrations of the same molecule in 2 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
Hong KongDraximage Mdp Kit For The Preparation Of Technetium Tc 99m Medronate InjectionRit Biotech Company LimitedRegisteredDH Drug Office
Hong KongMdp Sun Pharma Kit For The Preparation Of Technetium Tc 99m Medronate For Injection 20mgGlobal Medical Solutions Hong Kong LimitedRegisteredDH Drug Office
MaltaROTOP- MDP, 5.0 mg Kit for radio pharmaceutical preparationEJ Busuttil LtdKit For Radiopharmaceutical PreparationAuthorisedMedicines Authority

See every manufacturer of Medronic Acid worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Draximage Mdp-25 (DIN 02329239) marketed in Canada?

Yes. Health Canada lists DIN 02329239 as Marketed as of 23 Aug 2018.

Who holds the Canadian licence for this product?

Jubilant Draximage Inc. Dba Jubilant Radiopharma is the company of record in the Health Canada Drug Product Database.

Is Medronic Acid registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 2 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02329239, status date 2018-08-23; national medicine registries: DH Drug Office, Medicines Authority. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02329239, status date 2018-08-23; national medicine registries: DH Drug Office, Medicines Authority.

Health Canada Drug Product Database (DPD), DIN 02329239, status date 2018-08-23; national medicine registries: DH Drug Office, Medicines Authority. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.